Improving cancer drug development for diverse populations
Research Education
This study is working to make cancer treatments better for everyone by encouraging more Latino/Hispanic and African-American people to get involved in cancer research, so that the next generation of researchers truly represents the diverse communities in Southern California.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of California Riverside NIH-funded |
| Lab location | 1 site (Riverside, United States) |
| Project ID | NIH-10933481 on NIH RePORTER |
What this research studies
This research aims to address the disparities in cancer drug development that predominantly favor European-Americans by enhancing the participation of Latino/Hispanic-American and African-American communities. The project focuses on building a collaborative research education core between the University of California at Riverside and the City of Hope Comprehensive Cancer Center. It will develop training programs and research infrastructure to cultivate a new generation of therapeutics researchers who reflect the ethnic diversity of Inland Southern California. By integrating research experiences and educational outreach, the initiative seeks to ensure that future cancer treatments are more inclusive and effective for all populations.
Who could benefit from this research
Good fit: Ideal candidates for participation or benefit from this research include Latino/Hispanic-American and African-American individuals affected by cancer.
Not a fit: Patients who do not identify as Latino/Hispanic-American or African-American may not receive direct benefits from this research.
Why it matters
Potential benefit: If successful, this research could lead to more effective cancer treatments tailored to the needs of diverse populations.
How similar studies have performed: Other research initiatives have shown success in addressing health disparities through community engagement and inclusive research practices.
Where this research is happening
Riverside, United States
- University of California Riverside — Riverside, United States (Active)
Researchers
- Principal investigator: Pellecchia, Maurizio — University of California Riverside
- Study coordinator: Pellecchia, Maurizio
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.